High-throughput docking for the identification of new influenza A virus polymerase inhibitors targeting the PA-PB1 protein-protein interaction.

A high-throughput molecular docking approach was successfully applied for the selection of potential inhibitors of the Influenza RNA-polymerase which act by targeting the PA-PB1 protein-protein interaction. Commercially available compounds were purchased and biologically evaluated in vitro using an ELISA-based assay. As a result, some compounds possessing a 3-cyano-4,6-diphenyl-pyridine nucleus emerged as effective inhibitors with the best ones showing IC50 values in the micromolar range.

[1]  R. de Caterina,et al.  From asthma to atherosclerosis--5-lipoxygenase, leukotrienes, and inflammation. , 2004, The New England journal of medicine.

[2]  Erik De Clercq,et al.  Antiviral agents active against influenza A viruses , 2006, Nature Reviews Drug Discovery.

[3]  Hideo Goto,et al.  Avian flu: Isolation of drug-resistant H5N1 virus , 2005, Nature.

[4]  L. Goracci,et al.  Human Cytomegalovirus Inhibitor AL18 Also Possesses Activity against Influenza A and B Viruses , 2012, Antimicrobial Agents and Chemotherapy.

[5]  R. Frank,et al.  Identification of High-Affinity PB1-Derived Peptides with Enhanced Affinity to the PA Protein of Influenza A Virus Polymerase , 2010, Antimicrobial Agents and Chemotherapy.

[6]  M. Schwemmle,et al.  Identification of influenza virus inhibitors which disrupt of viral polymerase protein-protein interactions. , 2011, Methods.

[7]  Mark von Itzstein,et al.  The war against influenza: discovery and development of sialidase inhibitors , 2007, Nature Reviews Drug Discovery.

[8]  Richard D. Taylor,et al.  Improved protein–ligand docking using GOLD , 2003, Proteins.

[9]  H. Hsieh,et al.  Strategies of development of antiviral agents directed against influenza virus replication. , 2007, Current pharmaceutical design.

[10]  Giorgio Palù,et al.  Small molecule inhibitors of influenza A and B viruses that act by disrupting subunit interactions of the viral polymerase , 2012, Proceedings of the National Academy of Sciences.

[11]  A. Joachimiak,et al.  Crystal structure of the polymerase PAC–PB1N complex from an avian influenza H5N1 virus , 2008, Nature.

[12]  H. Doerr,et al.  Of chickens and men: avian influenza in humans. , 2009, Current molecular medicine.

[13]  Yi Guan,et al.  Oseltamivir resistance during treatment of influenza A (H5N1) infection. , 2005, The New England journal of medicine.

[14]  E. Obayashi,et al.  The structural basis for an essential subunit interaction in influenza virus RNA polymerase , 2008, Nature.

[15]  A Flahault,et al.  Influenza vaccine: the challenge of antigenic drift. , 2007, Vaccine.

[16]  R. Webster,et al.  Are We Ready for Pandemic Influenza? , 2003, Science.

[17]  M. Botta,et al.  Discovery and synthesis of novel benzofurazan derivatives as inhibitors of influenza A virus. , 2013, Bioorganic & medicinal chemistry letters.